Chicago billionaire Eric Lefkofsky has started five companies, none of which would seem to lead him to found a company that’s trying to cure cancer. Yet investors just gave his newest, two-year-old concern, Tempus, $70 million in Series C funding to do just that. No doubt they’re attracted to the company’s mission, which is to amass large quantities of genomic and clinical… Read More...